All posts tagged "ApTOLL"

Neuroprotective Effects of ApTOLL, a TLR4 Receptor Angatonist for Treating Ischemic Stroke

and 2023 International Stroke Congress (ISC)held February 8-10 in Dallas, Texas. Published findings From a double-blind, randomized, controlled phase 1a/2b trial evaluating the investigational drug ApTOLL...